2nd Tracking & Reporting Aggregate Spend

Why should you attend the 2nd Tracking & Reporting Aggregate Spend conference?

• Healthcare reform is now a reality and federal reporting requirements will be mandatory. Gain a solid understanding of the Physician Payment Sunshine Act in the healthcare reform bill and what your company must do to ensure compliance.

• Hear best practices from legislators and senior level pharmaceutical, biotech and medical device speakers

• Take home practical strategies for ensuring that your data capture systems are compliant, efficient and reliable

• This event features roundtables and panel discussions to allow for discussion of issues and solutions across companies. The intimate roundtables provide a safe environment for the exchange of ideas related to challenges and best practices.

• Hear case studies from companies that are ahead of the curve with the implementation of cost effective and compliant aggregate spend capture systems

In an effort to improve transparency in healthcare, provisions of the long deliberated Physician Payment Sunshine Act have officially been passed as part of federal Healthcare Reform. Beginning in 2013, pharmaceutical, biotech and medical device companies will be required to track and submit reports on spend associated with physicians across the nation. This includes payments in the form of honoraria, gifts, food, education, grants, and compensation for speaking engagements, to name a few. At the same time, companies must also comply with additional disclosure requirements and gift bans mandated by individual states. While the industry awaits specific guidance on implementation of the federal legislation, companies must take action now to ensure that they are prepared to meet the 2013 submission deadline for information related to 2012 spend.

Complying with the complex federal and state disclosure laws demands an enormous amount of time, effort and resources from individual companies. Anyone who interacts with healthcare providers must be trained on how to track spend, automated solutions need to be purchased to replace or supplement old systems, and the collected data need to be audited and eventually submitted as accurate and comprehensive reports. The challenges are great, and the costs associated with violating regulations will be severe.

ExL Pharma’s 2nd Tracking and Reporting Aggregate Spend conference provides attendees with concrete strategies for managing the compliance burden and minimizing risk. The expert speaking faculty shares best practices for how companies can prepare themselves for federal regulations while meeting additional state requirements, and ensure that corporate objectives are simultaneously being met. We look forward to greeting you in Washington, DC in January!